Lavender Bina Cendikia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Lavender Bina Cendikia Tbk. trades at Rp30 (market cap 30.9B, 2.96M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 5.4× Lavender Bina Cendikia Tbk.'s market cap, and Lavender Bina Cendikia Tbk. is more actively traded (2.96M versus 71K). Which is the better fit depends on your goals.
| BMBL | OBAT | |
|---|---|---|
Market Cap | 30.9B | 167.37B |
Volume | 2.96M | 71K |
Lot | 29.64K | 710 |
Turnover | 88.75M | 17.51M |
Average Price | 29.94 | 246.63 |
Value | 88.75M | 17.51M |
Indicative Equilibrium Price | 30 | 246 |
Indicative Equilibrium Volume | 1 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lavender Bina Cendikia Tbk ("Company") was established on November 27, 2013 based on theNotarial deed of Suparman Hasyim, S.H., No. 35. The Company started its commercial operations in2013. The ultimate beneficial owner of the Company is Galih Pandekar.
Read more on BMBL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →